subscribeSubscribe
Compass gets US FDA fast track for its bispecific DLL4/VEGF-A antibody, CTX-009

Compass gets US FDA fast track for its bispecific DLL4/VEGF-A antibody, CTX-009
PHARMABIZ
27 Apr 2024
Share Share
Compass Gets FDA Fast Track For CTX-009 + Pacli in Pre-Treated Biliary Cancer

Compass Gets FDA Fast Track For CTX-009 + Pacli in Pre-Treated Biliary Cancer
GLOBENEWSWIRE
25 Apr 2024
Share Share
Ratiopharm`s Pazenir (paclitaxel) Receives Approval in Europe

Ratiopharm`s Pazenir (paclitaxel) Receives Approval in Europe
EMA
11 Jan 2024
Share Share
GSK`s cancer drug combination meets primary goal in late-stage trial

GSK`s cancer drug combination meets primary goal in late-stage trial

PRESS RELEASE
19 Dec 2023
Share Share
Adlai Nortye Announces Completion of Patient Enrollment in PIII of Buparlisib

Adlai Nortye Announces Completion of Patient Enrollment in PIII of Buparlisib
GLOBENEWSWIRE
17 Nov 2023
Share Share
Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial

Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial
BUSINESSWIRE
28 Aug 2023
Share Share
BMS, BeiGene end legacy Celgene deal years after China ban

BMS, BeiGene end legacy Celgene deal years after China ban
Angus Liu FIERCE PHARMA
04 Aug 2023
Share Share
Pelareorep & Paclitaxel Induces Responses in Metastatic HR+/HER2– Breast Cancer

Pelareorep & Paclitaxel Induces Responses in Metastatic HR+/HER2– Breast Cancer
Chris Ryan ONCLIVE
03 Jul 2023
Share Share
Intra-arterial Gemcitabine Improves OS in Locally Advanced Pancreatic Cancer

Intra-arterial Gemcitabine Improves OS in Locally Advanced Pancreatic Cancer
Chris Ryan ONCLIVE
30 Jun 2023
Share Share
Journal of Clinical Oncology Publishes Results of Corcept™s Ph2 of Relacorilant

Journal of Clinical Oncology Publishes Results of Corcept™s Ph2 of Relacorilant
GLOBENEWSWIRE
27 Jun 2023
Share Share